Back to Journals » Journal of Hepatocellular Carcinoma » Volume 8 » default

Journal of Hepatocellular Carcinoma


Archive: Volume 8, 2021

Dicer Enhances Bevacizumab-Related Inhibition of Hepatocellular Carcinoma via Blocking the Vascular Endothelial Growth Factor Pathway

Wang C, Lv Y, Sha Z, Zhang J, Wu J, Qi Y, Guo Z

Journal of Hepatocellular Carcinoma 2021, 8:1643-1653

Published Date: 29 December 2021

Key Candidate Prognostic Biomarkers Correlated with Immune Infiltration in Hepatocellular Carcinoma

Deng Z, Huang K, Liu D, Luo N, Liu T, Han L, Du D, Lian D, Zhong Z, Peng J

Journal of Hepatocellular Carcinoma 2021, 8:1607-1622

Published Date: 18 December 2021

Clinical Characteristics, Treatment Patterns, and Healthcare Costs and Utilization for Hepatocellular Carcinoma (HCC) Patients Treated at a Large Referral Center in Washington State 2007–2018

Shankaran V, Chennupati S, Sanchez H, Sun Q, Li L, Fedorenko C, Aly A, Healey M, Seal B

Journal of Hepatocellular Carcinoma 2021, 8:1597-1606

Published Date: 14 December 2021

Experimental Validation of Novel Glypican 3 Exosomes for the Detection of Hepatocellular Carcinoma in Liver Cirrhosis

Aydin Y, Koksal AR, Thevenot P, Chava S, Heidari Z, Lin D, Sandow T, Moroz K, Parsi MA, Scott J, Cohen A, Dash S

Journal of Hepatocellular Carcinoma 2021, 8:1579-1596

Published Date: 8 December 2021

Yttrium-90 Radioembolization Is Associated with Better Clinical Outcomes in Patients with Hepatocellular Carcinoma Compared with Conventional Chemoembolization: A Propensity Score-Matched Study

Kim MA, Jang H, Choi NR, Nam JY, Lee YB, Cho EJ, Lee JH, Yu SJ, Kim HC, Chung JW, Yoon JH, Kim YJ

Journal of Hepatocellular Carcinoma 2021, 8:1565-1577

Published Date: 7 December 2021

Re-Recognizing the Cellular Origin of the Primary Epithelial Tumors of the Liver

Feng J, Zhu R, Yin Y, Wang S, Zhou L, Lv F, Zhao D

Journal of Hepatocellular Carcinoma 2021, 8:1537-1563

Published Date: 7 December 2021

Donafenib-Loaded Callispheres Beads Embolization in a VX2 Liver Tumor: Investigating Efficacy, Safety, and Improvement of Tumor Angiogenesis After Embolization

Li T, Shi Q, Liu J, Wang Y, Zhou C, Wang C, Ju S, Huang S, Yang C, Chen Y, Bai Y, Xiong B

Journal of Hepatocellular Carcinoma 2021, 8:1525-1535

Published Date: 3 December 2021

Inflammatory Scores: Comparison and Utility in HCC Patients Undergoing Transarterial Chemoembolization in a North American Cohort

Young S, Cam I, Gencturk M, Rubin N, D'souza D, Flanagan S, Golzarian J, Sanghvi T

Journal of Hepatocellular Carcinoma 2021, 8:1513-1524

Published Date: 1 December 2021

PRRC2A Promotes Hepatocellular Carcinoma Progression and Associates with Immune Infiltration

Liu X, Zhang Y, Wang Z, Liu L, Zhang G, Li J, Ren Z, Dong Z, Yu Z

Journal of Hepatocellular Carcinoma 2021, 8:1495-1511

Published Date: 1 December 2021

Antibiotic Therapy is Associated with Worse Outcome in Patients with Hepatocellular Carcinoma Treated with Sorafenib

Pomej K, Balcar L, Scheiner B, Semmler G, Meischl T, Mandorfer M, Reiberger T, Müller C, Trauner M, Pinter M

Journal of Hepatocellular Carcinoma 2021, 8:1485-1493

Published Date: 30 November 2021

Drug-Eluting Bead Transarterial Chemoembolization Combined with FOLFOX-Based Hepatic Arterial Infusion Chemotherapy for Large or Huge Hepatocellular Carcinoma

Huang J, Huang W, Zhan M, Guo Y, Liang L, Cai M, Lin L, He M, Lian H, Lu L, Zhu K

Journal of Hepatocellular Carcinoma 2021, 8:1445-1458

Published Date: 26 November 2021

Wnt/β-Catenin Signaling as a Driver of Hepatocellular Carcinoma Progression: An Emphasis on Molecular Pathways

Deldar Abad Paskeh M, Mirzaei S, Ashrafizadeh M, Zarrabi A, Sethi G

Journal of Hepatocellular Carcinoma 2021, 8:1415-1444

Published Date: 25 November 2021

Molecular Signature and Immune Landscape of HCV-Associated Hepatocellular Carcinoma (HCC): Differences and Similarities with HBV-HCC

De Battista D, Zamboni F, Gerstein H, Sato S, Markowitz TE, Lack J, Engle RE, Farci P

Journal of Hepatocellular Carcinoma 2021, 8:1399-1413

Published Date: 21 November 2021

Role of Rab GTPases in Hepatocellular Carcinoma

Yang CC, Meng GX, Dong ZR, Li T

Journal of Hepatocellular Carcinoma 2021, 8:1389-1397

Published Date: 19 November 2021

Increased Serum Pentraxin 3 Levels are Associated with Poor Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma

Han Q, Deng H, Fan X, Wang X, Zhang X, Zhang K, Li N, Lv Y, Liu Z

Journal of Hepatocellular Carcinoma 2021, 8:1367-1373

Published Date: 13 November 2021

CYP2C8 Suppress Proliferation, Migration, Invasion and Sorafenib Resistance of Hepatocellular Carcinoma via PI3K/Akt/p27kip1 Axis

Zhou X, Li TM, Luo JZ, Lan CL, Wei ZL, Fu TH, Liao XW, Zhu GZ, Ye XP, Peng T

Journal of Hepatocellular Carcinoma 2021, 8:1323-1338

Published Date: 3 November 2021

Dynamic Changes in Neutrophil-to-Lymphocyte Ratio are Associated with Survival and Liver Toxicity Following Stereotactic Body Radiotherapy for Hepatocellular Carcinoma

Hsiang CW, Huang WY, Yang JF, Shen PC, Dai YH, Wang YF, Lin CS, Chang WC, Lo CH

Journal of Hepatocellular Carcinoma 2021, 8:1299-1309

Published Date: 29 October 2021

Machine Learning to Improve Prognosis Prediction of Early Hepatocellular Carcinoma After Surgical Resection [Corrigendum]

Ji GW, Fan Y, Sun DW, Wu MY, Wang K, Li XC, Wang XH

Journal of Hepatocellular Carcinoma 2021, 8:1297-1298

Published Date: 27 October 2021

Response Stratification in the First-Line Combined Immunotherapy of Hepatocellular Carcinoma at Genomic, Transcriptional and Immune Repertoire Levels

Cheng J, Li Y, Wang X, Dong Z, Chen Y, Zhang R, Huang J, Jin X, Yao J, Ge A, Song L, Lu Y, Zeng Z

Journal of Hepatocellular Carcinoma 2021, 8:1281-1295

Published Date: 27 October 2021

Scirrhous Hepatocellular Carcinoma: Systematic Review and Pooled Data Analysis of Clinical, Radiological, and Histopathological Features

Murtha-Lemekhova A, Fuchs J, Schulz E, Sterkenburg AS, Mayer P, Pfeiffenberger J, Hoffmann K

Journal of Hepatocellular Carcinoma 2021, 8:1269-1279

Published Date: 22 October 2021

Antiviral Therapy Reduces Mortality in Hepatocellular Carcinoma Patients with Low-Level Hepatitis B Viremia

Wang X, Liu X, Wang P, Yu L, Yan F, Yan H, Zhou D, Yang Z

Journal of Hepatocellular Carcinoma 2021, 8:1253-1267

Published Date: 21 October 2021

Lenvatinib Combined with Anti-PD-1 Antibodies Plus Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study

Wu JY, Yin ZY, Bai YN, Chen YF, Zhou SQ, Wang SJ, Zhou JY, Li YN, Qiu FN, Li B, Yan ML

Journal of Hepatocellular Carcinoma 2021, 8:1233-1240

Published Date: 5 October 2021

Current Landscape and Future Directions of Biomarkers for Immunotherapy in Hepatocellular Carcinoma

Gok Yavuz B, Hasanov E, Lee SS, Mohamed YI, Curran MA, Koay EJ, Cristini V, Kaseb AO

Journal of Hepatocellular Carcinoma 2021, 8:1195-1207

Published Date: 24 September 2021

Percutaneous Therapies for Hepatocellular Carcinoma: Evolution of Liver Directed Therapies

Huber TC, Bochnakova T, Koethe Y, Park B, Farsad K

Journal of Hepatocellular Carcinoma 2021, 8:1181-1193

Published Date: 23 September 2021

Carbon Ion Radiotherapy in the Management of Hepatocellular Carcinoma

Abousaida B, Seneviratne D, Hoppe BS, Ko SJ, Asaithamby A, Cucinotta FA, Kirwan JM, Mody K, Toskich B, Ashman JB, Hallemeier CL, Krishnan S

Journal of Hepatocellular Carcinoma 2021, 8:1169-1179

Published Date: 24 September 2021

Impact of COVID-19 on Hepatocellular Carcinoma Management: A Multicountry and Region Study

Gandhi M, Ling WH, Chen CH, Lee JH, Kudo M, Chanwat R, Strasser SI, Xu Z, Lai SH, Chow PKH

Journal of Hepatocellular Carcinoma 2021, 8:1159-1167

Published Date: 23 September 2021

A Prospective Phase II Study of Safety and Efficacy of Sorafenib Followed by 90Y Glass Microspheres for Patients with Advanced or Metastatic Hepatocellular Carcinoma

Kaseb AO, Kappadath SC, Lee SS, Raghav KP, Mohamed YI, Xiao L, Morris JS, Ohaji C, Avritscher R, Odisio BC, Kuban J, Abdelsalam ME, Chasen B, Elsayes KM, Elbanan M, Wolff RA, Yao JC, Mahvash A

Journal of Hepatocellular Carcinoma 2021, 8:1129-1145

Published Date: 9 September 2021

Primary Liver Sarcomatoid Carcinoma: A Case Series and Literature Review

Ji W, Xing Y, Ma J, Zhao Z, Xu H, Zheng S, Li W, Li X

Journal of Hepatocellular Carcinoma 2021, 8:1117-1127

Published Date: 7 September 2021

Deep Learning-Based Prediction of Future Extrahepatic Metastasis and Macrovascular Invasion in Hepatocellular Carcinoma

Fu S, Pan M, Zhang J, Zhang H, Tang Z, Li Y, Mu W, Huang J, Dong D, Duan C, Li X, Wang S, Chen X, He X, Yan J, Lu L, Tian J

Journal of Hepatocellular Carcinoma 2021, 8:1065-1076

Published Date: 4 September 2021

A Genetic Variant of PPP1CB Influences Risk of Hepatitis B Virus-Related Hepatocellular Carcinoma in Han Chinese: A Pathway Based Analysis

Mai H, Xie H, Hou J, Chen H, Zhou B, Hou J, Jiang D

Journal of Hepatocellular Carcinoma 2021, 8:1055-1064

Published Date: 2 September 2021

Peptide-Based Vaccines for Hepatocellular Carcinoma: A Review of Recent Advances

Charneau J, Suzuki T, Shimomura M, Fujinami N, Nakatsura T

Journal of Hepatocellular Carcinoma 2021, 8:1035-1054

Published Date: 2 September 2021

Liver Cancer Survival: A Real World Observation of 45 Years with 32,556 Cases

Chen JG, Zhu J, Zhang YH, Chen YS, Ding LL, Chen HZ, Shen AG, Wang GR

Journal of Hepatocellular Carcinoma 2021, 8:1023-1034

Published Date: 31 August 2021

Regulation Network and Prognostic Significance of Aldo-Keto Reductase (AKR) Superfamily Genes in Hepatocellular Carcinoma

Dai T, Ye L, Yu H, Li K, Li J, Liu R, Lu X, Deng M, Li R, Liu W, Yang Y, Wang G

Journal of Hepatocellular Carcinoma 2021, 8:997-1021

Published Date: 30 August 2021

Molecular Targets of Ferroptosis in Hepatocellular Carcinoma

Liao H, Shi J, Wen K, Lin J, Liu Q, Shi B, Yan Y, Xiao Z

Journal of Hepatocellular Carcinoma 2021, 8:985-996

Published Date: 24 August 2021

Concurrent Sorafenib and Radiotherapy versus Radiotherapy Alone for Locally Advanced Hepatocellular Carcinoma: A Propensity-Matched Analysis

Liu CM, Huang BS, Yen YH, Wang YM, Huang EY, Hsu HC, Huang TT, Yang YH, Cheng JY

Journal of Hepatocellular Carcinoma 2021, 8:963-973

Published Date: 18 August 2021

Fine Mapping of the MHC Region Identifies Novel Variants Associated with HBV-Related Hepatocellular Carcinoma in Han Chinese

Mai H, Chen J, Chen H, Liu Z, Huang G, Wang J, Xiao Q, Ren W, Zhou B, Hou J, Jiang D

Journal of Hepatocellular Carcinoma 2021, 8:951-961

Published Date: 16 August 2021

Decreased Incidence of Hepatocellular Carcinoma after Directly Acting Antiviral Therapy in Patients with Hepatitis C–Related Advanced Fibrosis and Cirrhosis

Kilany S, Ata L, Gomaa A, Sabry A, Nada A, Tharwa ES, Badra G, Abogabal A, Elwaraky M, Moaz E, Ezzat S, Elsharawy A, Waked I

Journal of Hepatocellular Carcinoma 2021, 8:925-935

Published Date: 12 August 2021

Machine Learning to Improve Prognosis Prediction of Early Hepatocellular Carcinoma After Surgical Resection

Ji GW, Fan Y, Sun DW, Wu MY, Wang K, Li XC, Wang XH

Journal of Hepatocellular Carcinoma 2021, 8:913-923

Published Date: 10 August 2021

SLC39A10 Upregulation Predicts Poor Prognosis, Promotes Proliferation and Migration, and Correlates with Immune Infiltration in Hepatocellular Carcinoma

Ma Z, Li Z, Wang S, Zhou Q, Ma Z, Liu C, Huang B, Zheng Z, Yang L, Zou Y, Zhang C, Huang S, Hou B

Journal of Hepatocellular Carcinoma 2021, 8:899-912

Published Date: 7 August 2021

PD-1 Blockade for Hepatocellular Carcinoma: Current Research and Future Prospects

D'Alessio A, Rimassa L, Cortellini A, Pinato DJ

Journal of Hepatocellular Carcinoma 2021, 8:887-897

Published Date: 5 August 2021

DTYMK Expression Predicts Prognosis and Chemotherapeutic Response and Correlates with Immune Infiltration in Hepatocellular Carcinoma

Guo Y, Luo W, Huang S, Zhao W, Chen H, Ma Y, Ye M, Nie Y, Zhang Y, Huang C, Zhou Q, He X, Chen M

Journal of Hepatocellular Carcinoma 2021, 8:871-885

Published Date: 3 August 2021

Biochemical Safety of Ablative Yttrium-90 Radioembolization for Hepatocellular Carcinoma as a Function of Percent Liver Treated

De la Garza-Ramos C, Overfield CJ, Montazeri SA, Liou H, Paz-Fumagalli R, Frey GT, McKinney JM, Ritchie CA, Devcic Z, Lewis AR, Harnois DM, Patel T, Toskich BB

Journal of Hepatocellular Carcinoma 2021, 8:861-870

Published Date: 30 July 2021

Using the aMAP Risk Score to Predict Late Recurrence Following Radiofrequency Ablation for Hepatocellular Carcinoma in Chinese Population: A Multicenter Study

Yang Y, Zhou Y, Zhang X, Xin Y, Chen Y, Fan Q, Li X, Wei X, Li Q, Zhou X, Zhou J

Journal of Hepatocellular Carcinoma 2021, 8:837-850

Published Date: 28 July 2021

DNA and RNA Sequencing Recapitulated Aberrant Tumor Metabolism in Liver Cancer Cell Lines

Sun Y, Tang X, Ye B, Ding K

Journal of Hepatocellular Carcinoma 2021, 8:823-836

Published Date: 27 July 2021

An Exploratory Study for the Association of Gut Microbiome with Efficacy of Immune Checkpoint Inhibitor in Patients with Hepatocellular Carcinoma

Shen YC, Lee PC, Kuo YL, Wu WK, Chen CC, Lei CH, Yeh CP, Hsu C, Hsu CH, Lin ZZ, Shao YY, Lu LC, Liu TH, Chen CH, Wu MS, Huang YH, Cheng AL

Journal of Hepatocellular Carcinoma 2021, 8:809-822

Published Date: 24 July 2021

Preoperative Prediction of Cytokeratin 19 Expression for Hepatocellular Carcinoma with Deep Learning Radiomics Based on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging

Chen Y, Chen J, Zhang Y, Lin Z, Wang M, Huang L, Huang M, Tang M, Zhou X, Peng Z, Huang B, Feng ST

Journal of Hepatocellular Carcinoma 2021, 8:795-808

Published Date: 22 July 2021

SERPINA11 Inhibits Metastasis in Hepatocellular Carcinoma by Suppressing MEK/ERK Signaling Pathway

Song Y, Li Z, Li L, Zhou H, Zeng TT, Jin C, Lin JR, Gao S, Li Y, Guan XY, Zhu YH

Journal of Hepatocellular Carcinoma 2021, 8:759-771

Published Date: 6 July 2021

Elucidating the Molecular Basis of Sorafenib Resistance in HCC: Current Findings and Future Directions

Fornari F, Giovannini C, Piscaglia F, Gramantieri L

Journal of Hepatocellular Carcinoma 2021, 8:741-757

Published Date: 2 July 2021

Outcomes in the Era of Interferon-Free Direct-Acting Antiviral Therapy After Liver Transplantation in Patients with Hepatitis C Virus and Hepatocellular Carcinoma

Ismail MS, Mohamed I, Polychronopoulou E, Goss JA, Kuo YF, Kanwal F, Jalal PK

Journal of Hepatocellular Carcinoma 2021, 8:701-711

Published Date: 29 June 2021

Inhibition of SIRT1 Limits Self-Renewal and Oncogenesis by Inducing Senescence of Liver Cancer Stem Cells

Wang MJ, Chen JJ, Song SH, Su J, Zhao LH, Liu QG, Yang T, Chen Z, Liu C, Fu ZR, Hu YP, Chen F

Journal of Hepatocellular Carcinoma 2021, 8:685-699

Published Date: 29 June 2021

A Semi-Automatic Step-by-Step Expert-Guided LI-RADS Grading System Based on Gadoxetic Acid-Enhanced MRI

Sheng R, Huang J, Zhang W, Jin K, Yang L, Chong H, Fan J, Zhou J, Wu D, Zeng M

Journal of Hepatocellular Carcinoma 2021, 8:671-683

Published Date: 29 June 2021

Prognostic Values of Alpha-Fetoprotein and Des-Gamma-Carboxyprothrombin in Hepatocellular Carcinoma in China: An Analysis of 4792 Patients

Pan YX, Sun XQ, Hu ZL, Xie W, Nie KX, Fang AP, Zhang YY, Fu YZ, Chen JB, Wang JC, Wang X, Zhang YJ, Hu DD, Chen MS

Journal of Hepatocellular Carcinoma 2021, 8:657-670

Published Date: 25 June 2021

An Optimized Integrin α6-Targeted Magnetic Resonance Probe for Molecular Imaging of Hepatocellular Carcinoma in Mice

Lin BQ, Zhang WB, Zhao J, Zhou XH, Li YJ, Deng J, Zhao Q, Fu G, Xie CM, Xu YK, Feng GK

Journal of Hepatocellular Carcinoma 2021, 8:645-656

Published Date: 24 June 2021

Challenges Facing Percutaneous Ablation in the Treatment of Hepatocellular Carcinoma: Extension of Ablation Criteria

Zhou Y, Yang Y, Zhou B, Wang Z, Zhu R, Chen X, Ouyang J, Li Q, Zhou J

Journal of Hepatocellular Carcinoma 2021, 8:625-644

Published Date: 21 June 2021

Clinical Characteristics of Long-Term Survivors After Sorafenib Treatment for Unresectable Hepatocellular Carcinoma: A Korean National Multicenter Retrospective Cohort Study

Cho YY, Yu SJ, Lee HW, Kim DY, Kang W, Paik YH, Sung PS, Bae SH, Park SC, Doh YS, Kim KM, Jang ES, Kim IH, Kim W, Kim YJ

Journal of Hepatocellular Carcinoma 2021, 8:613-623

Published Date: 18 June 2021

Effectiveness of Transarterial Chemoembolization-First Treatment for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis

Chung SW, Park MK, Cho YY, Park Y, Lee CH, Oh H, Jang H, Kim MA, Kim SW, Nam JY, Lee YB, Cho EJ, Yu SJ, Kim HC, Kim YJ, Chung JW, Yoon JH, Lee JH

Journal of Hepatocellular Carcinoma 2021, 8:587-598

Published Date: 15 June 2021

Rates of Hepatocellular Carcinoma After Start of Treatment for Chronic Hepatitis C Remain High with Direct Acting Antivirals: Analysis from a Swiss Liver Transplant Center

Karbeyaz F, Kissling S, Jaklin PJ, Bachofner J, Brunner B, Müllhaupt B, Winder T, Mertens JC, Misselwitz B, von Felten S, Siebenhüner AR

Journal of Hepatocellular Carcinoma 2021, 8:565-574

Published Date: 11 June 2021

The Combination Immunotherapy of TLR9 Agonist and OX40 Agonist via Intratumoural Injection for Hepatocellular Carcinoma

Zhou Z, Lin L, An Y, Zhan M, Chen Y, Cai M, Zhu X, Lu L, Zhu K

Journal of Hepatocellular Carcinoma 2021, 8:529-543

Published Date: 8 June 2021

Up-to-Date Role of CT/MRI LI-RADS in Hepatocellular Carcinoma

Moura Cunha G, Chernyak V, Fowler KJ, Sirlin CB

Journal of Hepatocellular Carcinoma 2021, 8:513-527

Published Date: 31 May 2021

Clinical Indicators for Long-Term Survival with Immune Checkpoint Therapy in Advanced Hepatocellular Carcinoma

Monge C, Xie C, Steinberg SM, Greten TF

Journal of Hepatocellular Carcinoma 2021, 8:507-512

Published Date: 31 May 2021

Prognostic Model for the Risk Stratification of Early and Late Recurrence in Hepatitis B Virus-Related Small Hepatocellular Carcinoma Patients with Global Histone Modifications

Duan JL, Nie RC, Xiang ZC, Chen JW, Deng MH, Liang H, Wang FW, Luo RZ, Xie D, Cai MY

Journal of Hepatocellular Carcinoma 2021, 8:493-505

Published Date: 28 May 2021

Regorafenib Combined with Other Systemic Therapies: Exploring Promising Therapeutic Combinations in HCC

Granito A, Marinelli S, Forgione A, Renzulli M, Benevento F, Piscaglia F, Tovoli F

Journal of Hepatocellular Carcinoma 2021, 8:477-492

Published Date: 26 May 2021

The Prognostic Role of On-Treatment Liver Stiffness for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B

Lee HW, Lee HW, Lee JS, Roh YH, Lee H, Kim SU, Park JY, Kim DY, Ahn SH, Kim BK

Journal of Hepatocellular Carcinoma 2021, 8:467-476

Published Date: 25 May 2021

The Mechanisms of HBV-Induced Hepatocellular Carcinoma

Jiang Y, Han Q, Zhao H, Zhang J

Journal of Hepatocellular Carcinoma 2021, 8:435-450

Published Date: 20 May 2021

Phase I Trial on Arterial Embolization with Hypoxia Activated Tirapazamine for Unresectable Hepatocellular Carcinoma

Abi-Jaoudeh N, Dayyani F, Chen PJ, Fernando D, Fidelman N, Javan H, Liang PC, Hwang JI, Imagawa DK

Journal of Hepatocellular Carcinoma 2021, 8:421-434

Published Date: 17 May 2021

Current Strategies to Identify Patients That Will Benefit from TACE Treatment and Future Directions a Practical Step-by-Step Guide

Müller L, Stoehr F, Mähringer-Kunz A, Hahn F, Weinmann A, Kloeckner R

Journal of Hepatocellular Carcinoma 2021, 8:403-419

Published Date: 13 May 2021

Hepatocellular Carcinoma: An Overview of the Changing Landscape of Treatment Options

Koulouris A, Tsagkaris C, Spyrou V, Pappa E, Troullinou A, Nikolaou M

Journal of Hepatocellular Carcinoma 2021, 8:387-401

Published Date: 13 May 2021

MicroRNAs as Modulators of Tumor Metabolism, Microenvironment, and Immune Response in Hepatocellular Carcinoma

Gramantieri L, Giovannini C, Piscaglia F, Fornari F

Journal of Hepatocellular Carcinoma 2021, 8:369-385

Published Date: 12 May 2021

Impact of Sarcopenia on Two-Year Mortality in Patients with HCV-Associated Hepatocellular Carcinoma After Radiofrequency Ablation

Salman A, Salman M, Moustafa A, Shaaban HE, El-Mikkawy A, Labib S, Youssef A, Omar MG, Matter M, Elkassar H

Journal of Hepatocellular Carcinoma 2021, 8:313-320

Published Date: 29 April 2021

Development of Prognostic Evaluation Model to Predict the Overall Survival and Early Recurrence of Hepatocellular Carcinoma

Zhong Y, Yang Y, He L, Zhou Y, Cheng N, Chen G, Zhao B, Wang Y, Wang G, Liu X

Journal of Hepatocellular Carcinoma 2021, 8:301-312

Published Date: 29 April 2021

Serum Levels of ITGBL1 as an Early Diagnostic Biomarker for Hepatocellular Carcinoma with Hepatitis B Virus Infection

Ye F, Huang W, Xue Y, Tang E, Wang M, Shi F, Wei D, Han Y, Chen P, Zhang X, Yu D

Journal of Hepatocellular Carcinoma 2021, 8:285-300

Published Date: 27 April 2021

ARHGAP20 Expression Inhibited HCC Progression by Regulating the PI3K-AKT Signaling Pathway

Liu G, Li J, Zhang CY, Huang DY, Xu JW

Journal of Hepatocellular Carcinoma 2021, 8:271-284

Published Date: 21 April 2021

Ultrasound-Guided Percutaneous Ethanol-Paclitaxel Combined Therapy for Rabbit VX2 Liver Tumors

Chen L, Liu ZX, Bi QC, Zhao J, Liang QR, Tang Q

Journal of Hepatocellular Carcinoma 2021, 8:263-270

Published Date: 20 April 2021

NAFLD-Associated HCC: Progress and Opportunities

Geh D, Anstee QM, Reeves HL

Journal of Hepatocellular Carcinoma 2021, 8:223-239

Published Date: 8 April 2021

High Expression of PIGC Predicts Unfavorable Survival in Hepatocellular Carcinoma

Guo X, Tian S, Cao P, Xie Y, Dong W

Journal of Hepatocellular Carcinoma 2021, 8:211-222

Published Date: 6 April 2021

Development and Validation of a Metabolic Gene-Based Prognostic Signature for Hepatocellular Carcinoma

Weng J, Zhou C, Zhou Q, Chen W, Yin Y, Atyah M, Dong Q, Shi Y, Ren N

Journal of Hepatocellular Carcinoma 2021, 8:193-209

Published Date: 29 March 2021

The Role of Cabozantinib as a Therapeutic Option for Hepatocellular Carcinoma: Current Landscape and Future Challenges

D'Alessio A, Prete MG, Cammarota A, Personeni N, Rimassa L

Journal of Hepatocellular Carcinoma 2021, 8:177-191

Published Date: 29 March 2021

Anti-PD-1 Immunotherapy Improves the Efficacy of Hepatic Artery Infusion Chemotherapy in Advanced Hepatocellular Carcinoma

Mei J, Li SH, Li QJ, Sun XQ, Lu LH, Lin WP, Zheng L, Chen MS, Shi M, Wei W, Guo RP

Journal of Hepatocellular Carcinoma 2021, 8:167-176

Published Date: 25 March 2021

Recurrence of Hepatocellular Carcinoma After Liver Transplantation is Associated with Episodes of Acute Rejections

Gül-Klein S, Kästner A, Haber PK, Krenzien F, Wabitsch S, Krannich A, Andreou A, Eurich D, Tacke F, Horst D, Pratschke J, Schmelzle M

Journal of Hepatocellular Carcinoma 2021, 8:133-143

Published Date: 18 March 2021

A Novel Metabolism-Related Signature as a Candidate Prognostic Biomarker for Hepatocellular Carcinoma

Wang Z, Embaye KS, Yang Q, Qin L, Zhang C, Liu L, Zhan X, Zhang F, Wang X, Qin S

Journal of Hepatocellular Carcinoma 2021, 8:119-132

Published Date: 16 March 2021

Association of Postoperative Biomarker Response with Recurrence and Survival in Patients with Hepatocellular Carcinoma and High Alpha-Fetoprotein Expressions (>400 ng/ml)

Liang L, Wang MD, Zhang YM, Zhang WG, Zhang CW, Lau WY, Shen F, Pawlik TM, Huang DS, Yang T

Journal of Hepatocellular Carcinoma 2021, 8:103-118

Published Date: 12 March 2021

Gene Expression Profile and Prognostic Value of m6A RNA Methylation Regulators in Hepatocellular Carcinoma

Chang X, Lv YF, He J, Cao Y, Li CQ, Guo QN

Journal of Hepatocellular Carcinoma 2021, 8:85-101

Published Date: 12 March 2021

Imaging, Pathology, and Immune Correlates in the Woodchuck Hepatic Tumor Model

Mauda-Havakuk M, Mikhail AS, Starost MF, Jones EC, Karim B, Kleiner DE, Partanen A, Esparza-Trujillo JA, Bakhutashvili I, Wakim PG, Kassin MT, Lewis AL, Karanian JW, Wood BJ, Pritchard WF

Journal of Hepatocellular Carcinoma 2021, 8:71-83

Published Date: 9 March 2021

Radiation-Associated Lymphopenia and Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Radiotherapy

De B, Ng SP, Liu AY, Avila S, Tao R, Holliday EB, Brownlee Z, Kaseb A, Lee S, Raghav K, Vauthey JN, Minsky BD, Herman JM, Das P, Smith GL, Taniguchi CM, Krishnan S, Crane CH, Grassberger C, Hong TS, Lin SH, Koong AC, Mohan R, Koay EJ

Journal of Hepatocellular Carcinoma 2021, 8:57-69

Published Date: 3 March 2021

Mechanisms Underlying Hepatocellular Carcinoma Progression in Patients with Type 2 Diabetes

Shi T, Kobara H, Oura K, Masaki T

Journal of Hepatocellular Carcinoma 2021, 8:45-55

Published Date: 11 February 2021

Recent Update on the Role of Circular RNAs in Hepatocellular Carcinoma

Ely A, Bloom K, Maepa MB, Arbuthnot P

Journal of Hepatocellular Carcinoma 2021, 8:1-17

Published Date: 27 January 2021